| UHC UMR Medical and Drug | Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Motorized Spinal Traction - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Negative Pressure Wound Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Nerve Graft to Restore Erectile Function During Radical Prostatectomy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Neurophysiologic Testing and Monitoring - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Noncontact Warming Therapy, Ultrasound Therapy, and Fluorescence Imaging for Wounds - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Obstructive and Central Sleep Apnea Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Occipital Nerve Injections and Ablation (Including Occipital Neuralgia and Headache) - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Ocrevus® (Ocrelizumab) and Ocrevus Zunovo® (Ocrelizumab and Hyaluronidase-Ocsq) - Commercial Medical Benefit Drug Policy | 2026-01-01 |